Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab Consolidation in Follicular or Mantle Cell Lymphoma
NCT00003280Phase 3Completed
- Sponsor
- Swiss Group for Clinical Cancer Research
- Start
- Jan 1998
- Primary completion
- Mar 2002
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of rituximab in follicular lymphoma (FL), mantle cell lymphoma (MCL), sponsored by Swiss Group for Clinical Cancer Research. Started Jan 1998; status: completed.
02
Drugs
rituximab
03
Conditions
follicular lymphoma (FL)mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT00003280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003280.